Tralokinumab Monotherapy for Adolescent Subjects With Moderate to Severe Atopic Dermatitis - ECZTRA 6 (ECZema TRAlokinumab Trial no. 6).
Clinical trial NCT03526861 · COMPLETED
Trial details
- NCT number
- NCT03526861
- Sponsor
- LEO Pharma
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-19
- Primary completion
- 2020-04-15
- Enrollment
- 301
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.